Culbert, A A <br/><br/>
GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.  [electronic resource] 

 -  FEBS letters  Nov 2001 
 - 288-94 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-5793 
<br/><br/><label>Standard No.: </label>10.1016/s0014-5793(01)02990-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adenoviridae--genetics<br/>Aminophenols--pharmacology<br/>Animals<br/>Calcium-Calmodulin-Dependent Protein Kinases--antagonists & inhibitors<br/>Carrier Proteins<br/>Cytoplasm--metabolism<br/>Cytoskeletal Proteins--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation<br/>Glycogen Synthase Kinase 3<br/>Glycogen Synthase Kinases<br/>Indoles--pharmacology<br/>Maleimides--pharmacology<br/>Neoplasm Proteins<br/>Neurons--drug effects<br/>Neuroprotective Agents<br/>PC12 Cells<br/>Proto-Oncogene Proteins--genetics<br/>Rats<br/>Trans-Activators<br/>beta Catenin<br/>tau Proteins--metabolism